Loncar Lyon Jenkins continues to pursue Talc Powder litigation
Talc powder use has been controversial for decades. As far back as 1971 researchers were discovering talc particles embedded into the tumors of women with ovarian cancer. Nearly 20 peer-reviewed studies since 1971 have indicated a statistical link between talc and ovarian cancer. While these studies indicate a statistical link between talc use and ovarian cancer, Johnson & Johnson contends the statistical link is minimal and that no causal link exists between ovarian cancer and talc use.
The FDA has never required talc distributors to inform consumers of any link between the use of their products and cancer. In 2005 the National Toxicology Program (supervised by the United States Dept. of Health and Human services) concluded that existing data did not support a conclusion that talc was a cancer-causing agent. However, in 2006 the International Agency for Research on Cancer, a department of the World Health Organization, classified talc as “possibly carcinogenic to humans”. They concluded that more study was necessary. Perhaps the least shocking development was the 2013 Cosmetic Ingredient Review panel’s conclusion that talc is safe. Given they are financially supported by the cosmetics manufacturers industry the panel’s results should be received with great skepticism.
To date, two talc powder cases have gone to trial. The first trial, filed in federal court in South Dakota, resulted in a perplexing verdict. The jury found that Johnson & Johnson and its affiliates failed to warn cancer patient Deane Berg of the risks associated with the use of their talc-based Shower to Shower. Oddly, the jury awarded Ms. Berg nothing in damages despite her ovarian cancer.
In addition to the question of whether or not talc itself causes cancer, some experts believe that impurities that are not removed from the talc are the actual cancer-inducing culprits. Asbestos and other impurities that cannot be separated from talc as part of the production process are to blame for the cancer numbers. These experts believe the industry’s arguments that talc is safe is a smokescreen; that the real problem with talc lies with the fact that other, naturally occurring minerals found when talc is mined are not properly separated from the talc in the production process, inadvertently exposing users to known carcinogens such as asbestos.
Good Morning America has an excellent segment on the link between Talc and Ovarian cancer. The evidence seems to point that Talcum powder does indeed cause an increased risk for ovarian cancer significant enough that Johnson & Johnson should have warned consumers.
While talc powder cases will be surrounded by controversy and debate for years to come, Loncar Lyon Jenkins will continue to remain at the forefront of womens’ health litigation. From Fen-Phen to Yaz, Lipitor to NuvaRing, Essure and Transvaginal mesh litigation, Loncar Lyon Jenkins is proud of its decades-long role in protecting women from Big Medicine.
If you or someone you love were diagnosed with ovarian cancer during or after using Johnson & Johnson Baby Powder or Shower to Shower use, you may be eligible for compensation. Contact Loncar Lyon Jenkins immediately for a free, confidential case evaluation using the form or by calling toll free at 800.285.4878. Johnson & Johnson talc product lawsuits are being evaluated on a contingency fee basis, meaning you pay nothing unless a recovery is obtained.